You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
司太立(603520.SH):擬出資2000萬元投資上海研諾醫藥
格隆匯 01-11 16:38

格隆匯 1 月 11日丨司太立(603520.SH)公佈,2021111公司上海研諾醫藥科技有限公司(上海研諾)及其原股東共同簽署了資協議。此次增資完成後,上海研諾註冊資金由原500萬元增至543.47826萬元。公司擬出資2000萬元(其中43.47826萬元認繳新增註冊資本,其餘部分計入資本公積),將持有增值完成後上海研諾8.00%的股份

上海研諾專注於創新複雜注射劑的研發與商業化聚焦腫瘤、造影和麻醉領,已有多個2.21類創新複雜注射劑完成成藥性評,即將進入臨牀申報階段其核心技術團隊有十年以上的高端製劑研發、臨牀、生產及銷售經驗,擁有脂質體藥物研發平台、載藥乳劑研發平台、緩控球研發平台及納米粒藥物技術平台,全面覆蓋藥物傳輸系統的市場需求。此次投資完成後雙方將在藥物研發等多方面開展合作。上述合作有助於發揮雙方的資源和專業優勢加快公司的產業佈局,增強競爭力

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account